Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice.

Source:http://linkedlifedata.com/resource/pubmed/id/21102560

Download in:

View as

General Info

PMID
21102560